An early clinical trial involving 20 participants in China suggests that pulmonary stem cell transplants could benefit patients with chronic obstructive pulmonary disease (COPD). The participants had stage 2 to stage 4 COPD and were between the ages of 40 and 75 years.
No takes yet. Share an insight, caveat, or question.
Samantha Anderer (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: